YOLFTbeta
Carl Zeiss Meditec AG

Carl Zeiss Meditec AG

AFX · XETRA · Healthcare / Medical Instruments & Supplies

35.00EUR+0.56 (+1.63%)

Price History

Full chart

Market Stats

Previous Close34.44
Open34.36
Day Range34.32 – 35.22
52-Week Range22.12 – 47.30
Volume63.93K
Market Cap2.74B
P/E (TTM)22.85
Forward P/E21.46
EPS1.37
Dividend Yield1.76%
Beta1.35
50-Day Avg30.88
200-Day Avg28.85

About

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, including slit lamps, refractometers, and tonometers; optical coherence tomography and fundus cameras for retina examination; functional glaucoma diagnostic devices (perimeters); surgical ophthalmology products comprising surgical microscopes, biometers, and phacoemulsification and vitrectomy equipment; intraocular lenses for cataract surgery; and systems and consumables for laser eye surgery that include the VISUMAX femtosecond laser, which enables minimally invasive correction of vision defects using lenticular extraction, as well as digital products for the storage, analysis, and sharing of clinical data. The Microsurgery segment provides products and solutions for minimally invasive surgical treatments, including surgical visualization, interoperative radiotherapy, interoperative pathology, special surgical instruments, and digital solutions, as well as the ZEISS Tumor Workflow, a cross-product workflow solution. It serves physicians in various fields and hospitals. The company has a strategic collaboration with Envision Health Technologies Inc. to help advance glaucoma care through gamified virtual reality technology. The company was founded in 1846 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG operates as a subsidiary of ZEISS Group.

Company Details

Leadership

  • Mr. Justus Felix WehmerCFO & Member of the Management Board · b. 1965
  • Dr. Christian MunsterHead of Global Regulatory & Clinical Affairs, CoCe Site Jena & Emp. Rep. Member of Supervisory Board · b. 1971
  • Mr. Andreas PecherInterim Chairman of the Management Board & Interim CEO · b. 1971
  • Stefanie SpanagelChief Operating Officer
  • Mr. Sebastian FrericksDirector of Investor Relations
  • Eva-Maria HeineChief Human Resources Officer
  • Mr. Steven C. Schallhorn M.D.Chief Medical Officer for Global Ophthalmic Devices
  • Mr. Andrew ChangHead of Sales for Ophthalmic Devices & President of Carl Zeiss Meditec, Inc.
  • Dr. Euan S. Thomson Ph.D.President of Ophthalmic Devices and Head of the Ophthalmic Devices Strategic & Digital Business Unit · b. 1963
  • Mr. Magnus ReibenspiessHead of the Microsurgery Strategic Business Unit - ZEISS Medical Technology

Financials

Income Statement

Currency: EUR2005-09-302006-09-302007-09-302008-09-302009-09-302010-09-302011-09-302012-09-302013-09-302014-09-302015-09-302016-09-302017-09-302018-09-302019-09-302020-09-302021-09-302022-09-302023-09-302024-09-302025-09-30
Total Revenue323.67M390.56M569.70M600.19M640.09M676.68M758.79M861.88M906.45M909.25M1.04B1.09B1.19B1.28B1.46B1.34B1.65B1.90B2.09B2.07B2.23B
Growth (%)-+20.67%+45.87%+5.35%+6.65%+5.72%+12.13%+13.58%+5.17%+0.31%+14.39%+4.64%+9.33%+7.64%+13.93%-8.49%+23.31%+15.55%+9.80%-1.11%+7.82%
Cost of Revenue171.42M206.80M274.18M296.75M317.80M318.00M343.96M400.51M418.99M420.88M500.38M508.82M533.16M570.47M627.44M589.93M679.57M775.24M883.53M977.50M1.05B
Gross Profit152.25M183.76M295.52M303.44M322.29M358.69M414.84M461.36M487.46M488.37M539.68M579.55M656.73M710.39M831.88M745.52M967.21M1.13B1.21B1.09B1.18B
Gross Margin47.04%47.05%51.87%50.56%50.35%53.01%54.67%53.53%53.78%53.71%51.89%53.25%55.19%55.46%57.00%55.83%58.73%59.26%57.71%52.69%52.76%
Operating Expense117.00M135.67M225.16M235.22M246.21M271.98M311.27M338.46M354.85M367.67M409.09M425.21M484.43M513.26M567.23M538.91M593.60M730.72M857.64M894.18M951.88M
Operating Income35.26M48.09M70.36M68.21M76.08M86.70M103.57M122.90M132.61M120.70M130.59M154.33M172.30M197.13M264.66M206.60M373.61M396.88M348.12M194.45M223.32M
Operating Margin10.89%12.31%12.35%11.37%11.89%12.81%13.65%14.26%14.63%13.28%12.56%14.18%14.48%15.39%18.14%15.47%22.69%20.86%16.66%9.41%10.02%
EBITDA46.23M59.70M94.33M94.17M100.98M109.79M127.07M140.16M168.40M135.44M123.66M165.78M215.49M213.12M286.44M267.03M410.00M482.85M501.88M403.06M346.89M
EBITDA Margin14.28%15.28%16.56%15.69%15.78%16.22%16.75%16.26%18.58%14.90%11.89%15.23%18.11%16.64%19.63%20.00%24.90%25.38%24.02%19.51%15.57%
Net Income16.32M26.69M49.65M56.24M55.10M59.60M66.91M71.87M92.13M74.95M62.30M98.33M134.44M126.46M159.76M122.39M236.28M293.91M290.40M178.73M141.21M
Net Income Margin5.04%6.83%8.71%9.37%8.61%8.81%8.82%8.34%10.16%8.24%5.99%9.03%11.30%9.87%10.95%9.16%14.35%15.45%13.90%8.65%6.34%
R&D31.76M38.30M59.23M61.96M63.45M72.36M84.22M93.45M97.58M99.75M111.96M123.41M145.79M159.63M173.31M218.80M232.07M291.37M349.28M343.09M326.27M
R&D as % of Total Revenue9.81%9.81%10.40%10.32%9.91%10.69%11.10%10.84%10.76%10.97%10.76%11.34%12.25%12.46%11.88%16.38%14.09%15.31%16.72%16.61%14.65%
Interest Expense3.52M3.37M6.39M5.71M6.00M5.88M7.17M6.08M6.59M1.99M1.51M2.15M1.68M2.05M7.65M27.27M8.58M9.10M15.25M14.58M26.62M
Interest Expense % of Total Revenue1.09%0.86%1.12%0.95%0.94%0.87%0.95%0.71%0.73%0.22%0.15%0.20%0.14%0.16%0.52%2.04%0.52%0.48%0.73%0.71%1.20%

Balance Sheet

Currency: EUR2005-09-302006-09-302007-09-302008-09-302009-09-302010-09-302011-09-302012-09-302013-09-302014-09-302015-09-302016-09-302017-09-302018-09-302019-09-302020-09-302021-09-302022-09-302023-09-302024-09-302025-09-30
Total Assets365.96M387.44M696.31M715.82M754.37M841.20M867.49M962.88M980.57M1.04B1.14B1.25B1.62B1.66B2.02B2.01B2.40B2.82B3.03B3.39B3.46B
Total Liabilities160.56M164.35M215.06M215.09M214.59M242.22M233.43M267.08M245.74M284.88M341.84M396.57M381.37M347.42M605.17M562.73M718.59M792.73M860.02M1.34B1.33B
Total Equity205.41M223.09M471.61M487.99M520.85M572.28M599.04M654.99M698.41M715.27M753.86M797.84M1.22B1.29B1.40B1.43B1.66B2.02B2.16B2.04B2.12B
Cash50.00M46.64M217.92M195.47M200.00M313.52M194.64M9.53M6.29M10.73M13.04M8.71M3.92M6.68M22.64M5.20M7.44M7.73M10.60M20.29M27.27M
Total Debt--44.51M19.60M18.23M18.19M10.70M30.91M14.31M13.25M13.14M10.59M6.41M10.85M166.50M156.15M197.77M219.68M297.72M612.73M607.37M
Net Debt-50.00M-46.64M-173.41M-175.88M-181.76M-295.32M-183.94M21.38M8.03M2.52M-817.00K270.00K1.89M4.17M34.85M63.40M113.83M120.17M287.12M592.44M580.10M

Cash Flow

Currency: EUR2005-09-302006-09-302007-09-302008-09-302009-09-302010-09-302011-09-302012-09-302013-09-302014-09-302015-09-302016-09-302017-09-302018-09-302019-09-302020-09-302021-09-302022-09-302023-09-302024-09-302025-09-30
Operating Cash Flow45.83M55.51M56.08M54.87M87.36M65.21M37.55M92.10M64.62M63.10M56.74M111.77M37.73M187.21M219.63M178.53M362.66M188.20M250.86M247.32M209.86M
Investing Cash Flow-107.95M-26.11M-18.27M-24.78M-30.59M-8.45M-120.25M-37.40M-32.20M-49.44M-35.17M77.33M-55.93M-28.87M-145.85M-71.95M-75.20M-148.89M-110.98M-412.31M-91.03M
Financing Cash Flow68.89M-19.27M134.54M-49.71M-52.23M54.99M-39.85M-242.87M-34.19M-7.52M-19.29M-195.02M14.49M-157.24M-58.64M-122.96M-285.89M-38.24M-135.09M176.25M-108.83M
Capital Expenditure006.65M13.01M16.39M11.66M6.49M25.25M10.64M18.12M16.77M27.92M39.02M34.76M46.71M44.99M66.10M81.97M113.86M152.20M39.39M
Free Cash Flow45.83M55.51M49.42M41.87M70.96M53.55M31.05M66.84M53.98M44.98M39.97M83.85M-1.29M152.45M172.92M133.54M296.56M106.23M137.00M95.11M170.46M
Dividends Paid--11.38M34.96M14.64M14.64M44.72M24.39M32.52M36.59M32.52M30.90M37.56M49.19M49.19M58.14M44.72M80.50M98.39M98.20M52.52M
FCF to OCF100.00%100.00%88.13%76.30%81.24%82.12%82.70%72.58%83.53%71.28%70.44%75.02%-3.42%81.43%78.73%74.80%81.77%56.44%54.61%38.46%81.23%
Dividend Paid to FCF--23.03%83.51%20.62%27.33%144.02%36.49%60.25%81.34%81.37%36.85%-2912.02%32.27%28.45%43.53%15.08%75.78%71.81%103.25%30.81%

Earnings

Report DateDec 31, 2000Mar 31, 2001Jun 30, 2001Sep 30, 2001Dec 31, 2001Mar 31, 2002Jun 30, 2002Sep 30, 2002Dec 31, 2003Mar 31, 2004Jun 30, 2004Dec 15, 2004Feb 11, 2005May 12, 2005Aug 12, 2005Feb 13, 2006May 15, 2006Aug 14, 2006Dec 13, 2006May 15, 2007Aug 14, 2007Dec 12, 2007Feb 14, 2008May 13, 2008Aug 14, 2008Dec 9, 2008Feb 13, 2009May 14, 2009Aug 13, 2009Dec 14, 2009Feb 12, 2010Apr 29, 2010Aug 12, 2010Nov 16, 2010Feb 11, 2011May 5, 2011Aug 15, 2011Dec 8, 2011Feb 14, 2012May 16, 2012Aug 16, 2012Dec 19, 2012Feb 20, 2013May 14, 2013Aug 14, 2013Dec 5, 2013Feb 14, 2014May 10, 2014Aug 15, 2014Dec 17, 2014Feb 11, 2015Apr 21, 2015Aug 8, 2015Dec 16, 2015Feb 12, 2016May 11, 2016Aug 12, 2016Dec 9, 2016Feb 15, 2017May 11, 2017Aug 7, 2017Dec 8, 2017Feb 12, 2018May 15, 2018Aug 10, 2018Dec 7, 2018Feb 11, 2019May 6, 2019Aug 23, 2019Dec 6, 2019Feb 10, 2020May 11, 2020Sep 24, 2020Dec 12, 2020Feb 16, 2021May 28, 2021Sep 1, 2021Dec 10, 2021Feb 10, 2022May 13, 2022Aug 4, 2022Dec 9, 2022Feb 15, 2023May 14, 2023Aug 5, 2023Dec 11, 2023Jan 11, 2024May 6, 2024Aug 6, 2024Dec 9, 2024Feb 11, 2025May 11, 2025Aug 7, 2025Dec 9, 2025Feb 11, 2026May 11, 2026Aug 4, 2026Dec 10, 2026
EPS Estimate-----------0.11--0.110.190.150.190.180.140.160.16-0.130.14-0.16-0.11-0.140.140.140.190.180.190.19-0.200.270.220.210.290.270.25-0.230.260.250.28-0.190.26-0.260.310.280.370.230.380.330.340.310.400.330.530.360.000.000.570.420.320.280.330.520.680.920.600.420.700.690.830.570.690.770.750.750.480.550.510.280.470.530.570.200.270.380.39
EPS Actual0.080.01-0.28-0.680.040.04-1.461.530.090.080.070.080.100.090.100.130.130.160.250.140.140.210.140.160.150.220.160.130.110.220.140.120.130.270.170.230.200.220.210.280.170.220.290.230.290.340.250.240.220.210.210.140.270.120.210.380.240.380.380.430.320.380.330.310.300.500.320.330.570.570.440.290.280.600.520.610.920.600.421.030.721.170.570.691.031.021.020.440.431.010.360.580.380.590.030.450.54-
Surprise------------27.27%---9.09%-31.58%-13.33%-15.79%38.89%0.00%-12.50%31.25%-23.08%7.14%-0.00%-0.00%-0.00%-14.29%-7.14%42.11%-5.56%21.05%5.26%-5.00%3.70%-22.73%4.76%0.00%-14.81%16.00%-8.70%-7.69%-12.00%-25.00%--26.32%3.85%--19.23%22.58%-14.29%2.70%65.22%13.16%-3.03%11.76%6.45%-22.50%-9.09%-5.66%-11.11%--0.00%4.76%-9.38%0.25%81.82%0.00%-10.29%0.00%0.00%0.00%47.14%4.35%40.96%0.00%0.00%33.77%36.00%36.00%-8.33%-21.82%98.04%28.57%23.40%-28.30%3.51%-85.00%66.67%42.11%-
Timing-----------Pre-market--Pre-marketPre-market---Pre-marketPre-marketPre-market-Pre-marketPre-market-Pre-market-Pre-market-Pre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketAfter-hours-After-hoursAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursAfter-hours-After-hoursPre-marketPre-marketPre-market-Pre-marketPre-market-After-hoursPre-marketPre-marketAfter-hours--After-hours-After-hoursAfter-hoursAfter-hoursAfter-hours----Pre-marketPre-market-Pre-market-Pre-market-Pre-market-After-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-market

Key Statistics & Ratios

Market Cap2.74B
Enterprise Value4.06B
Trailing P/E22.85
Forward P/E21.46
PEG Ratio1.23
Price / Sales1.26
Price / Book1.91
EPS1.37
Book Value23.98
Revenue (TTM)2.18B
Gross Profit (TTM)1.12B
EBITDA217.84M
Profit Margin5.57%
Operating Margin11.06%
Return on Equity4.54%
Return on Assets2.74%
Shares Outstanding87.54M
Shares Float34.19M
Beta1.35
Dividend Yield1.76%
Dividend Rate0.55
Payout Ratio34.16%

Dividends

20261×
0.55Mar 27, 2026
20251×
0.60Mar 27, 2025
20241×
1.10Mar 22, 2024
20231×
1.10Mar 23, 2023
20221×
0.90Mar 31, 2022
20211×
0.50May 28, 2021
20202×
0.65Aug 7, 20200.65Mar 25, 2020
20191×
0.55Mar 20, 2019
20181×
0.55Apr 11, 2018
20171×
0.42May 31, 2017
20161×
0.38Apr 7, 2016
20151×
0.40Mar 19, 2015
20141×
0.45Mar 5, 2014
20131×
0.40Mar 6, 2013
20121×
0.30Mar 12, 2012
20111×
0.55Apr 13, 2011
20101×
0.18Mar 5, 2010
20091×
0.18May 20, 2009
20081×
0.16Mar 10, 2008
20071×
0.14Mar 12, 2007
20061×
0.12Mar 13, 2006

Stock Splits

  • Oct 24, 2006894:653